What does the future hold for the manufacturing and clinical landscape? Pharma iQ asked Precision leaders Scott Marshall, PhD and Jeremy Schafer, PharmD, MBA. From gene therapy cures for chronic diseases to continuing price pressure on manufacturers, the role of machine learning to the role of companion diagnostics, their insights point the way to major developments in 2019.
To read the full article, click here
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
